Based on observations, review of clinical records, review of facility policy/procedure and interviews for 2 of 14 residents (Resident #87 and #162) observed during medication administration (2 of 25 medications administered) resulting in an error rate of 8%, the facility failed to ensure a medication error rate below 5%. The findings include:Observation on 8/12/26 at 12:17 PM of methadone administration for Resident #162 identified LPN #6 provided Resident #162 with a methadone bottle, with a label that identified the resident was receiving 70mg with a concentration of 10mg/ml which equals 7ml, which the resident consumed. The current physician's order identified a methadone concentration of 10mg/5ml for a dose of 70mg which would be 35ml and not 7ml. …
F759 citations in Connecticut
Medication error rate · Pharmacy Service Deficiencies
Ensure medication error rates are not 5 percent or greater.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Connecticut cites F759 less often than its own record predicts
0.35 times the national share — cited less often here than elsewhere.
Of every deficiency written in Connecticut in 2025, this is the portion that was F759.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Connecticut surveyors wrote
F759 findings written in Connecticut, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
The short window
Recent years
| Year | Share of Connecticut citations | vs expected |
|---|---|---|
| 2023 | 0.34% | 0.27× |
| 2024 | 0.28% | 0.26× |
| 2025 | 0.37% | 0.35× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Connecticut surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction